Skip to main content
. 2014 Oct 20;36(1):49–59. doi: 10.1093/carcin/bgu213

Table IV.

Associations between subpathway genes and SNPs with rectal cancer that were used in polygenic score (P ARTP < 0.10)

Subpathway Gene Gene P ARTP SNP Genotype SNP P a OR 95% CIb
Angiogenesis MPO 0.041 rs2243828 AG/GG versus AA 0.039 0.81 (0.67, 0.99)
VEGFA 0.057 rs2010963 GC/CC versus GG 0.007 1.30 (1.07, 1.58)
Hormone/insulin/ growth IGF1R 0.079 IGF1R CC versus AA 0.078 1.51 (0.93, 2.43)
Interferons IFNGR1 0.052 rs3799488 CC versus TT/TC 0.040 2.30 (1.04, 5.08)
rs9376267 CT/TT versus CC 0.065 1.20 (0.99, 1.46)
IRF2 0.072 rs3775554 CC versus GG 0.057 1.06 (0.46, 2.44)
rs3775556 GG versus AA 0.007 1.48 (1.00, 2.20)
rs10009261 TT versus CC 0.038 0.77 (0.57, 1.04)
rs7677486 TT versus CC 0.003 1.54 (1.16, 2.03)
rs6827018 GG versus AA 0.032 1.70 (0.75, 3.83)
rs3733473 AA versus GG 0.078 0.97 (0.61, 1.53)
rs3775574 AG/GG versus AA 0.003 0.74 (0.60, 0.90)
Interleukins IL15 0.064 rs12508866 TC/CC versus TT 0.019 0.79 (0.65, 0.96)
rs17461269 TA/AA versus TT 0.025 1.25 (1.03, 1.52)
rs13117878 TT versus CC 0.066 1.29 (0.98, 1.69)
IL8RA 0.006 rs1008562 GG versus CC 0.001 1.57 (1.20, 2.05)
IL8RB 0.002 rs1126579 TT versus CC 0.001 1.56 (1.19, 2.05)
Jak/Stat/Socs STAT3 0.083 rs2293152 CC versus GG/GC 0.014 0.71 (0.54, 0.93)
STAT6 0.100 rs3024979 TA/AA versus TT 0.016 0.73 (0.56, 0.94)
MAPK DUSP1 0.030 rs322351 TT versus CC 0.013 1.43 (1.09, 1.88)
DUSP7 0.051 rs9851576 AG/GG versus AA 0.054 0.81 (0.66, 1.00)
MAPK8 0.055 rs10508901 AA versus CC/CA 0.023 1.45 (1.05, 1.99)
Pathway core NFKB1 0.017 rs230510 TT versus AA 0.006 0.67 (0.50, 0.90)
rs3821958 GG versus AA 0.043 1.35 (1.02, 1.78)
rs11722146 AA versus GG 0.015 1.42 (1.02, 1.97)
PIK3CA 0.077 rs2699905 GA/AA versus GG 0.054 0.82 (0.67, 1.00)
rs7651265 GG versus AA 0.063 2.38 (1.04, 5.43)
rs7640662 GG versus CC 0.012 0.30 (0.11, 0.79)
PIK3CG 0.019 rs4460309 TT versus CC 0.005 0.66 (0.43, 1.00)
rs11766675 GG versus AA 0.003 0.57 (0.34, 0.96)
RPS6KA2 0.072 rs10946164 CT/TT versus CC 0.020 0.78 (0.64, 0.96)
rs9347128 GG versus CC/CG 0.027 1.32 (1.03, 1.68)
rs1040446 TG/GG versus TT 0.038 0.78 (0.61, 0.99)
rs6911624 AA versus GG 0.002 0.55 (0.31, 0.98)
rs4709127 TT versus CC 0.047 0.74 (0.52, 1.06)
rs2345067 CC versus TT 0.035 0.75 (0.57, 0.98)
rs1202621 CC versus AA 0.073 1.25 (0.93, 1.68)
rs7745781 AG/GG versus AA 0.001 1.42 (1.15, 1.76)
RPS6KB2 0.057 rs1638588 AA versus CC 0.028 0.73 (0.56, 0.96)
TSC1 0.043 rs13295634 GG versus TT/TG 0.004 0.61 (0.43, 0.86)
Selenoproteins SEPN1 0.002 rs718391 GG versus CC 0.010 0.70 (0.53, 0.93)
rs2072749 GG versus AA 0.003 0.53 (0.35, 0.80)
rs11247735 AA versus GG/GA 0.021 1.31 (1.04, 1.64)
rs4659382 GG versus CC/CG 0.007 0.58 (0.39, 0.86)
SEPP1 0.092 rs3877899 AA versus GG 0.039 0.68 (0.43, 1.07)
rs11959466 GA/AA versus GG 0.019 1.46 (1.06, 2.00)
rs28919882 AG/GG versus AA 0.023 0.72 (0.55, 0.96)
TXNRD3 0.004 rs4679274 TT versus CC/CT 0.034 0.73 (0.54, 0.98)
rs9637365 TT versus CC/CT 0.006 0.70 (0.55, 0.90)
rs11718498 GA/AA versus GG 0.001 1.42 (1.15, 1.74)
TGFβ BMPR2 0.026 rs4675278 AA versus GG 0.087 1.29 (0.92, 1.81)
rs17199235 AG/GG versus AA 0.018 1.35 (1.05, 1.72)
rs2228545 GA/AA versus GG 0.002 1.93 (1.28, 2.91)
TNF NFAT5 0.030 rs12447326 TT versus CC/CT 0.003 0.60 (0.43, 0.84)
rs16959025 GG versus TT/TG 0.025 0.57 (0.35, 0.93)

Significant genes with P ARTP <0.05 are indicated in bold.

a P values based on 1-df Wald chi-square tests.

bModels adjusted for age, study center, race/ethnicity and sex.